Literature DB >> 25465277

[Treatment of chronic back pain: current standards].

E Märker-Hermann1, U Kiltz, J Braun.   

Abstract

Back pain is a significant medical problem and one of the most common causes of medical consultations and missed work. In acute low back pain, patients with "red flags" indicating a serious underlying spinal or extraspinal disease must be identified by medical evaluation. Most cases of acute back pain are non-specific, and education, physical activity and pain medication is recommended. In addition, yellow flags (risks of developing chronic pain) should be recognized. The management of low back pain has been addressed by the German National Disease Management Guideline (NVL) low back pain published in 2010. This guideline evaluates the evidence and effectiveness of diagnostic and therapeutic interventions with a focus on nonspecific back pain. For chronic nonspecific low back pain intervention based on nondrug and drug therapy and a multiprofessional assessment is recommended. In patients with chronic inflammatory low back pain with onset before the age of 45, rheumatic spondyloarthritis should be considered. Recently, a guideline (S3-Leitlinie) for the management of axial spondyloarthritis including ankylosing spondylitis has become available. It provides evidence of physical and drug therapy including nonsteroidal antirheumatic and Tumor necrosis factor (TNF) inhibitor therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25465277     DOI: 10.1007/s00108-014-3558-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

Review 1.  Diagnosis and treatment of low back pain.

Authors:  B W Koes; M W van Tulder; S Thomas
Journal:  BMJ       Date:  2006-06-17

2.  [Management of nonspecific low back pain. The new national guidelines 2011].

Authors:  M Rudwaleit; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

3.  Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.

Authors:  R D Sturrock; F D Hart
Journal:  Ann Rheum Dis       Date:  1974-03       Impact factor: 19.103

4.  Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.

Authors:  André Barkhuizen; Serge Steinfeld; Jeffery Robbins; Christine West; John Coombs; Samuel Zwillich
Journal:  J Rheumatol       Date:  2006-09       Impact factor: 4.666

Review 5.  Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.

Authors:  Johanna Callhoff; Joachim Sieper; Anja Weiß; Angela Zink; Joachim Listing
Journal:  Ann Rheum Dis       Date:  2014-04-09       Impact factor: 19.103

6.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

Review 7.  Overtreating chronic back pain: time to back off?

Authors:  Richard A Deyo; Sohail K Mirza; Judith A Turner; Brook I Martin
Journal:  J Am Board Fam Med       Date:  2009 Jan-Feb       Impact factor: 2.657

Review 8.  [Multimodal pain therapy: principles and indications].

Authors:  B Arnold; T Brinkschmidt; H-R Casser; I Gralow; D Irnich; K Klimczyk; G Müller; B Nagel; M Pfingsten; M Schiltenwolf; R Sittl; W Söllner
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

9.  2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Braun; R van den Berg; X Baraliakos; H Boehm; R Burgos-Vargas; E Collantes-Estevez; H Dagfinrud; B Dijkmans; M Dougados; P Emery; P Geher; M Hammoudeh; R D Inman; M Jongkees; M A Khan; U Kiltz; Tk Kvien; M Leirisalo-Repo; W P Maksymowych; I Olivieri; K Pavelka; J Sieper; E Stanislawska-Biernat; D Wendling; S Ozgocmen; C van Drogen; Bj van Royen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103

Review 10.  Long-term opioid management for chronic noncancer pain.

Authors:  Meredith Noble; Jonathan R Treadwell; Stephen J Tregear; Vivian H Coates; Philip J Wiffen; Clarisse Akafomo; Karen M Schoelles
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more
  3 in total

1.  [The AMDS system for the documentation of symptoms and signs associated with pain].

Authors:  Teja W Grömer; Wolfgang Käfferlein; Björn Menger; Ralf Dohrenbusch; Bernd Kappis; Christian Maihöfner; Johannes Kornhuber; Alexandra Philipsen; Helge H O Müller
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

2.  The relationship between levels of resilience and coping styles in chiropractic students and perceived levels of stress and well-being.

Authors:  Stanley I Innes
Journal:  J Chiropr Educ       Date:  2016-07-26

3.  Risk and protective factors in the clinical rehabilitation of chronic back pain.

Authors:  Pia-Maria Wippert; Michael Fliesser; Matthias Krause
Journal:  J Pain Res       Date:  2017-07-06       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.